Abstract
Erythromycin derivatives have been used as antibacterial drugs in clinic for many years. As lacking of relevant impurities, those drugs quality control are limited. So, we carried out a research of general reaction: synthesis of 3 “- N-demonomethyl - Erythromycin, 3 “- N-demonomethyl - Clarithromycin, 3 “- N- demonomethyl - Roxithromycin and 3 “- N-demonomethyl- Azithromycin by using Erythromycin, Clarithromycin, Roxithromycin and Azithromycin as the raw material respectively. Using 1HNMR, 13CNMR and MS identified those impurities structures. Our methods have many advantages: raw materials cheap, getting easily, safely and stability, high yield and good purity, and it also can use for quality control of Erythromycin derivatives and new drug development based on 3“-N-demonomenthyl macrolide compounds.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: IOP Conference Series: Materials Science and Engineering
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.